Exane BNP Paribas analyst Rob Jones downgraded Gecina to Neutral from Outperform with a EUR 120 price target. The analyst made rating changes in the European real estate sector as part of the firm’s 2024 outlook.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GECFF: